SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-054163
Filing Date
2021-08-31
Accepted
2021-08-31 19:32:41
Documents
1
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3425
  Complete submission text file 0001209191-21-054163.txt   5043
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address C/O ANGION BIOMEDICA CORP. 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 415-655-4899
EISA-ABC LLC (Reporting) CIK: 0001878914 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 211228368